Baker Ellis Asset Management LLC Sells 3,850 Shares of Lam Research Corporation $LRCX

Lam Research logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Baker Ellis Asset Management trimmed its Lam Research stake by 3.3% in Q1, selling 3,850 shares and leaving it with 112,622 shares worth about $24.1 million. Lam Research remains the firm’s third-largest holding, at 2.9% of its portfolio.
  • Lam Research reported strong quarterly results, with earnings of $1.47 per share and revenue of $5.84 billion, both above estimates. Revenue rose 23.8% year over year, and the company also issued upbeat Q4 2026 guidance.
  • Analysts remain broadly positive on LRCX despite one downgrade, with several firms raising price targets and a consensus rating of “Moderate Buy.” The average analyst price target is $329.59, while the stock recently traded near $409.54.
  • MarketBeat previews top five stocks to own in July.

Baker Ellis Asset Management LLC lowered its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 3.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 112,622 shares of the semiconductor company's stock after selling 3,850 shares during the period. Lam Research accounts for 2.9% of Baker Ellis Asset Management LLC's investment portfolio, making the stock its 3rd biggest position. Baker Ellis Asset Management LLC's holdings in Lam Research were worth $24,063,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC acquired a new stake in Lam Research in the 4th quarter worth about $25,000. Bayban acquired a new position in shares of Lam Research during the 4th quarter valued at about $26,000. Mcguire Capital Advisors Inc. acquired a new position in shares of Lam Research during the 4th quarter valued at about $27,000. Core Wealth Advisors LLC purchased a new position in shares of Lam Research during the 4th quarter worth about $29,000. Finally, University of Illinois Foundation purchased a new position in shares of Lam Research during the 4th quarter worth about $30,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Trading Up 5.3%

NASDAQ:LRCX opened at $409.54 on Tuesday. The business's 50-day moving average is $304.76 and its two-hundred day moving average is $243.95. The firm has a market capitalization of $512.16 billion, a PE ratio of 77.27, a price-to-earnings-growth ratio of 3.21 and a beta of 1.85. Lam Research Corporation has a 12 month low of $90.29 and a 12 month high of $409.75. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. During the same quarter in the prior year, the business earned $1.04 earnings per share. The company's revenue was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Research analysts predict that Lam Research Corporation will post 5.7 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Wednesday, June 17th. Lam Research's dividend payout ratio is currently 19.62%.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

Analysts Set New Price Targets

LRCX has been the subject of a number of recent analyst reports. Wall Street Zen downgraded shares of Lam Research from a "buy" rating to a "hold" rating in a report on Sunday, May 10th. Morgan Stanley raised shares of Lam Research from an "underweight" rating to an "overweight" rating and increased their price target for the stock from $293.00 to $331.00 in a research note on Monday, May 18th. UBS Group reiterated a "buy" rating and issued a $375.00 price target (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Berenberg Bank boosted their price objective on shares of Lam Research from $265.00 to $335.00 and gave the company a "buy" rating in a research note on Thursday, April 23rd. Finally, Mizuho set a $380.00 price objective on Lam Research and gave the stock an "outperform" rating in a report on Wednesday, May 27th. Twenty-eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Lam Research currently has a consensus rating of "Moderate Buy" and an average price target of $329.59.

Get Our Latest Stock Analysis on Lam Research

Insiders Place Their Bets

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares of the company's stock, valued at $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of Lam Research stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the sale, the insider owned 53,205 shares in the company, valued at $13,762,005.30. This represents a 10.15% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 86,339 shares of company stock worth $27,680,267 in the last 90 days. 0.31% of the stock is owned by company insiders.

Lam Research Profile

(Free Report)

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Recommended Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines